Downstream Processing Featured Articles

1. Novasep Launches The Sius Single-Use TFF Skid, Completing The First 100 Per Cent Single-Use TFF Solution For Pre-Clinical To Clinical cGMP Biomanufacturing 2/14/2013

   Novasep, a leading supplier of purification solutions to the life sciences industries, recently announces the launch of its Sius single-use tangential flow filtration (TFF) skid.

2. MicroRNAs Can Convert Normal Cells Into Cancer Promoters 11/21/2012

   Unraveling the mechanism that ovarian cancer cells use to change normal cells around them into cells that promote tumor growth has identified several new targets for treatment of this deadly disease.

3. New Gene Mutations Linked To ALS And Nerve Cell Growth Dysfunction 7/16/2012

   Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis - ALS, also known as Lou Gehrig's disease. 

4. BioChip May Make Diagnosis Of Leukemia And HIV Faster, Cheaper 5/30/2012

   Inexpensive, portable devices that can rapidly screen cells for leukemia or HIV may soon be possible thanks to a chip that can produce three-dimensional focusing of a stream of cells, according to researchers.

5. FDA Approves New Combination Vaccine That Protects Children Against Two Bacterial Diseases 6/14/2012

   The U.S. Food and Drug Administration recently approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.

6. Novavax Publishes Preclinical Efficacy Study Of Its RSV Protein Nanoparticle Vaccine Candidate 12/3/2012

   Novavax, Inc. (Nasdaq: NVAX) today announced that the journal PLOS ONE (http://dx.plos.org/10.1371/journal.pone.0050852) published data from a preclinical study of its recombinant nanoparticle vaccine candidate against respiratory syncytial virus (RSV), demonstrating efficacy and safety in a well-established animal model.

7. New Findings Challenge Established Views On Human Genome 6/13/2007
   ENCODE research consortium uncovers surprises An international research consortium today published a set of papers that promise to reshape our understanding of how the human genome functions
8. Biosensors & Big Data: Implications For Biologics Developers 10/13/2020

   Dr. Caroline Loew’s company, Glympse Bio, develops injectable, tunable biosensors that she says will help biologics developers test and measure disease progression in vivo, enabling valuable, early visibility into therapeutic efficacy. 

9. Selexys Pharmaceuticals Completes $23M Equity Financing And Signs Agreement With Global Pharmaceutical Company 9/20/2012

   Selexys Pharmaceuticals, Corp., announced today that it has successfully completed a $23 million Series A equity financing, led by MPM Capital. Additionally, Selexys entered into an agreement with Novartis Pharmaceuticals whereby Novartis has been granted an exclusive option to acquire Selexys and its lead asset, the anti-P-selectin antibody SelG1, following the successful completion of a Phase 2 clinical study in patients with sickle cell disease.

10. 3 Factors To Prevent Protein Aggregation For Your Protein Purification Buffer

    Before you purify your first batch of a new protein it is important to know what buffer you might want to use to keep precipitation of proteins to a minimum.